High Rate of Hepatitis C Virus Reinfection Among Recently Injecting Drug Users: Results From the TraP Hep C Program—A Prospective Nationwide, Population-Based Study von Johannesson, Jon M, Fridriksdottir, Ragnheidur H, Löve, Thorvardur J, Runarsdottir, Valgerdur, Hansdóttir, Ingunn, Löve, Arthur, Thordardottir, Marianna, Hernandez, Ubaldo B, Olafsson, Sigurdur, Gottfredsson, Magnus

Volltext

Cascade of care during the first 36 months of the treatment as prevention for hepatitis C (TraP HepC) programme in Iceland: a population-based study von Olafsson, Sigurdur, Fridriksdottir, Ragnheidur H, Love, Thorvardur J, Tyrfingsson, Thorarinn, Runarsdottir, Valgerdur, Hansdottir, Ingunn, Bergmann, Ottar M, Björnsson, Einar S, Johannsson, Birgir, Sigurdardottir, Bryndis, Löve, Arthur, Baldvinsdottir, Gudrun E, Hernandez, Ubaldo Benitez, Gudnason, Thorolfur, Heimisdottir, Maria, Hellard, Margaret, Gottfredsson, Magnus

Volltext

FRI438 - Reinfection with hepatitis C following cure: results from the TraP Hep C program in Iceland - a prospective nationwide, population-based study von Johannesson, Jon M, Olafsson, Sigurdur, Fridriksdottir, Ragnheidur H., Löve, Thorvardur J., Runarsdottir, Valgerdur, Sigmundsdottir, Gudrun, Löve, Arthur, Gottfredsson, Magnús

Volltext

Reinfection with hepatitis C following cure: results from the TraP Hep C program in Iceland - a prospective nationwide, population-based study von Johannesson, Jon M, Olafsson, Sigurdur, Fridriksdottir, Ragnheidur H., Löve, Thorvardur J., Runarsdottir, Valgerdur, Sigmundsdottir, Gudrun, Löve, Arthur, Gottfredsson, Magnús

Volltext

Sustained low prevalence of HCV viremia among people who inject drugs following the treatment as prevention for hepatitis C (TraP HepC) nationwide elimination program in Iceland von Gottfredsson, Magnús, Runarsdottir, Valgerdur, Löve, Thorvardur J., Fridriksdottir, Ragnheidur H., Tyrfingsson, Thorarinn, Hansdottir, Ingunn, Bergmann, Ottar M., Björnsson, Einar S., Johannsson, Birgir, Sigurdardottir, Bryndis, Löve, Arthur, Baldvinsdóttir, Guðrún Erna, Thordardottir, Marianna, Hernandez, Ubaldo Benitez, Heimisdottir, Maria, Olafsson, Sigurdur

Volltext

No restrictions should be placed on future treatment for patients who discontinue DAAs on their first or second attempt. A real world experience from the TraP HepC initiative in Ic... von Olafsson, Sigurdur, Löve, Thorvardur J., Fridriksdottir, Ragnheidur H., Tyrfingsson, Thorarinn, Runarsdottir, Valgerdur, Hansdottir, Ingunn, Bergmann, Ottar M., Björnsson, Einar S., Johannsson, Birgir, Sigurdardottir, Bryndis, Löve, Arthur, Baldvinsdóttir, Guðrún Erna, Sigmundsdottir, Gudrun, Hernandez, Ubaldo Benitez, Heimisdottir, Maria, Gottfredsson, Magnús

Volltext

SAT344 - No restrictions should be placed on future treatment for patients who discontinue DAAs on their first or second attempt. A real world experience from the TraP HepC initiat... von Olafsson, Sigurdur, Löve, Thorvardur J., Fridriksdottir, Ragnheidur H., Tyrfingsson, Thorarinn, Runarsdottir, Valgerdur, Hansdottir, Ingunn, Bergmann, Ottar M., Björnsson, Einar S., Johannsson, Birgir, Sigurdardottir, Bryndis, Löve, Arthur, Baldvinsdóttir, Guðrún Erna, Sigmundsdottir, Gudrun, Hernandez, Ubaldo Benitez, Heimisdottir, Maria, Gottfredsson, Magnús

Volltext

PS-072-Is homelessness the biggest hurdle to treatment success in the management of HCV in the era of direct acting antivirals? Results from the TraP HepC nationwide treatment init... von Gottfredsson, Magnús, Love, Thorvardur, Fridriksdottir, Ragnheidur H., Tyrfingsson, Thorarinn, Runarsdottir, Valgerdur, Hansdottir, Ingunn, Bergmann, Ottar M., Bjornsson, Einar S., Johannsson, Birgir, Sigurdardottir, Bryndis, Löve, Arthur, Sigmundsdottir, Gudrun, Josefsdottir, Kamilla, Hernandez, Ubaldo B., Heimisdottir, Maria, Olafsson, Sigurdur

Volltext

THU-412-Iceland may already have reached the WHO 2030 targets for diagnosis and treatment of hepatitis C virus infection: Results from the treatment as prevention for hepatitis C (... von Olafsson, Sigurdur, Fridriksdottir, Ragnheidur H., Tyrfingsson, Thorarinn, Runarsdottir, Valgerdur, Hansdottir, Ingunn, Bergmann, Ottar M., Björnsson, Einar S., Johannsson, Birgir, Sigurdardottir, Bryndis, Love, Arthur, Sigmundsdottir, Gudrun, Josefsdottir, Kamilla S, Hernandez, Ubaldo Benitez, Love, Thorvardur Jon, Heimisdottir, Maria, Gottfredsson, Magnús

Volltext

2895. Threats to Successful Elimination of Viral Hepatitis: Results from the Nationwide Treatment as Prevention for Hepatitis C (TraP HepC) Program in Iceland von Gottfredsson, Magnus, Runarsdottir, Valgerdur, Love, Thorvardur J, Fridriksdottir, Ragnheidur H, Sigurdardottir, Bryndis, Johannsson, Birgir, Bjornsson, Einar S, Bergmann, Ottar M, Love, Arthur, Sigmundsdottir, Gudrun, Tyrfingsson, Thorarinn, Olafsson, Sigurdur

Volltext

928. Major Decrease in Prevalence of Hepatitis C Viremia in Key Populations following the Second Year of Treatment as Prevention for Hepatitis C (TraP HepC) Program in Iceland von Gottfredsson, Magnus, Tyrfingsson, Thorarinn, Runarsdottir, Valgerdur, Hansdottir, Ingunn, Bergmann, Ottar M, Bjornsson, Einar S, Johannsson, Birgir, Sigurdardottir, Bryndis, Fridriksdottir, Ragnheidur H, Löve, Arthur, Löve, Thorvardur J, Sigmundsdottir, Gudrun, Hernandez, Ubaldo, Heimisdottir, Maria, Olafsson, Sigurdur

Volltext

Treatment as Prevention for Hepatitis C (TraP HepC). A Real-world Experience from the First 12 Months of a Nationwide Elimination Program in Iceland von Gottfredsson, Magnus, Tyrfingsson, Thorarinn, Runarsdottir, Valgerdur, Bergmann, Ottar M, Bjornsson, Einar S, Johannsson, Birgir, Sigurdardottir, Bryndis, Fridriksdottir, Ragnheidur H, Löve, Arthur, Löve, Thorvardur J, Sigmundsdottir, Gudrun, Heimisdottir, Maria, Olafsson, Sigurdur

Volltext